Literature data provided a valuable overview of the NF-κB/Nrf2/SIRT1 signaling target as a new strategy to counteract colitis, highlighting its pivotal role in IBDs and emphasizing the inhibition of NF-κB translocation and the modulation of Nrf2/SIRT1 signal through supplements or natural compounds. Here, NFKB1 is linked to colitis.